期刊文献+

抗BPl80NCl6AIgEELISA检测方法的建立 被引量:1

Establishment of enzyme-linked immunosorbent assay in the detection of BP180NC16A-specific IgE and its significance in bullous pemphigoid
原文传递
导出
摘要 目的建立抗BPl80NCl6AIgE抗体酶联免疫吸附试验(ELISA)检测方法,评价其在大疱性类天疱疮(BP)诊断中的意义。方法采用pGEX一2T原核表达GST—BPl80NCl6A融合蛋白,并用谷胱甘肽亲和层析法进行纯化。采用棋盘滴定法确定抗原包被浓度,明确二抗及待测标本最佳稀释度,确定最佳实验条件。对2011年2月至2012年10月就诊于北京协和医院的56例BP患者、24名健康对照以及18例天疱疮、1例Stevens—Johnson综合征(SJS)患者血清进行检测,根据受试者工作特征(ROC)曲线确定最优阳性界值并评价其敏感度和特异度。结果确定抗原包被浓度为500μg/ml、酶标二抗最佳稀释倍数为1:1000,血清标本采用原液及1:10为最佳实验条件。根据ROC曲线判断最优阳性界值为0.549,实验的敏感度为71.4%、特异度为100%。天疱疮和SJS患者血清中此抗体均为阴性。结论抗BPl80NCl6AIgE抗体检测方法具有较高的特异度以及相对较高的敏感度,在BP的诊断及发病机制的研究中具有重要意义。 Objective To establish a method of detecting circulating immunoglobulin E (IgE) autoantibodies for BPISONC16A and evaluate its significance in bullous pemphigoid (BP). Methods GST-NCI6A fusion proteins were expressed in Escherichia coli using the pGEX-2T expression system and purified by glutathione affinity chromatography. For optimal working conditions of enzyme-linked immunoabsorbent assay (ELISA), checkerboard titrations were performed with serial dilutions of antigen. Also optimized dilution of secondary antibody was confirmed. Sera samples from 56 patients with BP, 24 healthy controls, 18 with pemphigus and 1 with Stevens-Johnson syndrome at our hospital during February 2011 to October 2012 were exanfined by the modified ELISA approach. The optimal cut-off point for a positive result was selected with receiver operating characteristic analysis. Results The optimized ELISA was performed with plates coated with 500 μg/ml GST-NC16A. And the optimal dilutions of sera samples and secondary antibody were 1:10 and 1:1000 respectively. According to the established cut-off value (0. 549) , 40 of 56 BP patients and none of controls had detectable levels of BP180NCI6A IgE. Conclusion The established EHSA provides a highly specific tool for the detection of IgE anti-BP180NC16A in BP patients.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第28期2244-2247,共4页 National Medical Journal of China
基金 国家自然科学基金(81071301) 教育部新世纪优秀人才计划(NCET-10-0964)
关键词 类天疱疮 大疱性 免疫球蛋白E 酶联免疫吸附测定 抗BP180NC16A Pemphigoid, bullous Immunoglobulin E Enzyme-linked immunosorbent assay Anti-BP180NC16A
  • 相关文献

参考文献10

  • 1Messingham KA, Onoh A, Vanderah EM, et al. Functionalcharacterization of an IgE-class monoclonal antibody specific forthe bullous pemphigoid autoantigen, BP180. Hybridoma(Larchmt) ,2012 ,31 :111-117.
  • 2Fania L,Caldarola G, Miiller R , et al. IgE recognition of bullouspemphigoid ( BP) 180 and BP230 in BP patients and elderlyindividuals with pruritic dermatoses. Clin Immunol , 2012, 143 :236-245.
  • 3Fairley JA,Fu CL, Giudice GJ. Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid. JInvest Dermatol, 2005,125: 467-472.
  • 4左亚刚,LIU Zhi.抗BP180N C16A IgG亚型检测方法的建立以及在大疱性类天疱疮中的意义[J].中华皮肤科杂志,2012,45(6):384-387. 被引量:3
  • 5左亚刚,LIUZhi.大疱性类天疱疮和妊娠疱疹患者血清抗BP180NC16A抗体的纯化和鉴定[J].中华皮肤科杂志,2012,45(1):9-11. 被引量:2
  • 6Messingham KA, Noe MH,Chapman MA,et al. A novel ELISAreveals high frequencies of BP180-specific IgE production inbullous pemphigoid. J Immunol Methods, 2009 ,346 : 18-25.
  • 7Dopp R,Schmidt E,Chimanovitch I,et al. IgG4 and IgE are themajor immunoglobulins targeting the NC16A domain of BP180 inBullous pemphigoid : serum levels of these immunoglobulins reflectdisease activity. J Am Acad Dermatol,2000, 42: 577-583.
  • 8Fairley JA, Baum CL, Brandt DS, et al. Pathogenicityof TgE inautoimmunity : successful treatment of bullous pemphigoid withomalizumab. J Allergy Clin Immunol ,2009 ,123 :704-705.
  • 9Bamadas MA,Rubiales MV,Gonzalez MJ,et al. Enzyme-linkedimmunosorbent assay (ELJSA) and indirect immunofluorescencetesting in a bullous pemphigoid and pemphigoid gestationis. Int JDermatol, 2008 ,47 : 1245-1249.
  • 10Iwata Y, Komura K, Kodera M, et al. Correlation of IgEautoantibody to BP180 with a severe form of bullouspemphigoid. Arch Dermatol, 2008,144:4148.

二级参考文献19

  • 1Burgdorf W,Moreland A,Wasik R.Negative immunoperoxidase staining for lysozyme in nodular subepidermal fibrosis.Arch Dermatol,1982,118(4):241-243.
  • 2Bieber K,Sun Shijie,Ishii N,et al.Animal models for autoimmune bullous dermatoses.Exp Dermatol,2010,19(1):2-11.
  • 3Leuci S,Gürcan HM,Ahmed AR.Serological studies in bullous pemphigoid:a literature review of antibody titers at presentation and in clinical remission.Acta Derm Venereol.2010,90(2):115-121.
  • 4Feng Suying,Wu Qinxue,Jin Peiying,et al.Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.Int J Dermatol,2008,47(3):225-228.
  • 5Barnadas MA,Rubiales MV,González MJ,et al.Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis.Int J Dermatol,2008,47(12):1245-1249.
  • 6Liu Z,Sui W,Zhao M,Li Z,et al.Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.J Autoimmun,2008,31 (4):331-338.
  • 7Wong MM, Giudice GJ, Fairley JA. Autoimmunity in bullous pemphigoid. G Ital Dermatol Venereol, 2009, 144(4): 411-421.
  • 8Schmidt E, Zillikens D. Immunoadsorption in dermatology. Arch Dermatol Res, 2010, 302(4): 241-253.
  • 9Bieber K, Sun S, Ishii N, et al. Animal models for autoimmune bullous dermatoses. Exp Dermatol, 2010, 19( 1 ): 2-11.
  • 10Leighty L, Li N, Diaz LA, Liu Z. Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid. Arch Dermatol Res, 2007, 299(9): 417-422.

共引文献3

同被引文献14

  • 1Nishie W. Update on the pathogenesis of bullous pemphig- oid: an autoantibody-mediated blistering disease targeting collagen XVII[ J ]. J Dermatol Sci, 2014, 73 : 179- 186. doi: 10. 1016/j. jdermsci. 2013.12. 001.
  • 2Wu Y, Sun NN, Dang EL, et al. Anti-collagen XVII single- chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid [ J ]. J Dermatol Sci, 2013, 72 : 25-31. doi: 10. lO16/j, jdermsci. 2013.05. 010.
  • 3Ujiie H. IgE autoantibodies in bullous pemphigoid: sup- porting role, or leading player? [ J ]. J Dermatol Sci, 2015, 78 : 5-10. doi : 10. lO16/j, jdermsei. 2015.03. 002.
  • 4Moriuchi R, Nishie W, Ujiie H, et al. In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 eases [J]. J Dermatol Sci, 2015, 78: 21-25. doi: 10. lO16/j. jdermsci. 2015.01. 013.
  • 5Ishiura N, Fujimoto M, Watanabe R, et al. Serum levels of IgE anti-BPl80 and anti-BP230 autoantibodies in patients with bullous pemphigoid [ J]. J Dermatol Sci, 2008, 49: 153-161. doi : 10. lO16/j, jdermsci. 2007.08. 008.
  • 6Fairley JA, Fu CL, Giudice GJ. Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid[J]. J Invest Dermatol, 2005, 125: 467-472. doi: 10. llll/j. 0022-202X. 2005. 23853. x.
  • 7Murrell DF, Daniel BS, Joly P, et al. Definitions and out- come measures for bullous pemphigoid: recommendations by an international panel of experts [ J ]. J Am Acad Derma- tol, 2012, 66: 479-485. doi: 10. 1016/j. jaad. 2011. 06. 032.
  • 8Iwata Y,Komura K,Kodera M,et al. Correlation of IgE au- toantibody to BP180 with a severe form of buHous pemphig- oid[J]. Arch Dermatol, 2008, 144: 41-48. doi: 10. 1001/ arehdermatol. 2007.9.
  • 9Ma L, Wang M,Wang X,et al. Circulating IgE anti-BP180 autoantibody and its correlation to clinical and laboratorial aspects in bullous pemphigoid patients [ J ]. J Dermatol Sci, 2015, 78 : 76- 77. doi: 10. 1016/j. jdermsci. 2015. 02. 015.
  • 10van Beck N, Schulze FS,Zillikens D,et al. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases [J]. Expert Rev Clin Immunol, 2016, 12: 267-277. doi: 10. 1586/1744666x. 2016.1123092.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部